
How confident is the bio/pharma workforce heading into 2027? PharmTech wants to find out, and we need your input.
Dow AgroSciences Receives Regulatory Approval for Plant-Made Vaccine
Dow AgroSciences LLC (Indianapolis, IN,
The vaccine is produced from the “DowAgroSciences Concert Plant-Cell-Produced System” that uses plant cells instead of whole plants in a biocontained environment to produce vaccines. With the approval, Dow AgroSciences says that it can focus its efforts on developing vaccines for animal health and that using this technology for human vaccines is a possibility.





